Tenascin C levels in patients with mild and severe preeclampsia

dc.contributor.authorOrak, Ugur
dc.contributor.authorCelik, Ebru
dc.contributor.authorKavak, Salih Burcin
dc.contributor.authorDemirel, Ismail
dc.contributor.authorAtilgan, Remzi
dc.contributor.authorAydin, Suleyman
dc.contributor.authorSapmaz, Ekrem
dc.date.accessioned2026-08-12T17:16:59Z
dc.date.issued2016
dc.departmentFırat Üniversitesi
dc.description.abstractObjective: To determine the serum tenascin-C (TN-C) levels in cases with mild and severe preeclampsia.Methods: Pregnant women were divided into three groups, namely healthy pregnants (Group 1, n=20), pregnants with mild preeclampsia (Group 2, n=20) and pregnants with severe preeclampsia (Group 3, n=20). The groups were formed so as to match each other in terms of gestational week. From each pregnant woman, pre- and post-delivery blood samples were obtained to measure serum TN-C levels. The data were evaluated using the Kruskall-Wallis variance analysis. For the obtained values of p<0.05, the groups were compared in pairs. A p value of <0.017 was accepted as significant.Results: In Groups 1, 2 and 3, the prepartum TN-C levels were 5.020.4 mu g/ml, 12.8 +/- 2.9 mu g/ml and 33.8 +/- 11.7 mu g/ml, and in the postpartum TN-C levels were 4.7 +/- 0.1 mu g/ml, 11.7 +/- 1.8 mu g/ml and 50.6 +/- 33.8 mu g/ml, respectively. There was a significant difference between the groups in terms of the prepartum and postpartum TN-C levels (p<0.017, Mann-Whitney U [MWU] test). There was also a significant difference in the prepartum TN-C levels between Groups 2 and 3 (p<0.017, MWU test).Conclusions: The prepartum and postpartum TN-C levels were significantly higher in mild and severe preeclampsia than those in healthy pregnants.
dc.identifier.doi10.3109/14767058.2014.998191
dc.identifier.endpage273
dc.identifier.issn1476-7058
dc.identifier.issn1476-4954
dc.identifier.issue2
dc.identifier.orcid0000-0002-0774-4294
dc.identifier.pmid25567561
dc.identifier.scopus2-s2.0-84983189792
dc.identifier.scopusqualityQ1
dc.identifier.startpage270
dc.identifier.urihttps://doi.org/10.3109/14767058.2014.998191
dc.identifier.urihttps://hdl.handle.net/11508/52499
dc.identifier.volume29
dc.identifier.wosWOS:000365628300019
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofJournal of Maternal-Fetal & Neonatal Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectCytokine
dc.subjectpreeclampsia
dc.subjecttenascin-C
dc.titleTenascin C levels in patients with mild and severe preeclampsia
dc.typeArticle

Dosyalar